Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants-Reference-Cited by-同舟云学术

Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants

Published:2015-07-03 Issue:8 Volume:13 Page:1106-1120
ISSN:1467-7644
Container-title:Plant Biotechnology Journal
language:en
Short-container-title:Plant Biotechnol J

Author:

Ma Julian K-C.¹,Drossard Jürgen²³,Lewis David¹,Altmann Friedrich⁴,Boyle Julia⁵,Christou Paul⁶⁷,Cole Tom¹,Dale Philip⁸,van Dolleweerd Craig J.¹,Isitt Valerie¹,Katinger Dietmar⁹,Lobedan Martin²³,Mertens Hubert²³,Paul Mathew J.¹,Rademacher Thomas²³,Sack Markus²³,Hundleby Penelope A. C.⁸,Stiegler Gabriela⁹,Stoger Eva²³,Twyman Richard M.¹⁰,Vcelar Brigitta⁹,Fischer Rainer²³

Affiliation:

1. Molecular Immunology Unit; Institute for Infection and Immunity; St. George's University of London; London UK

2. Fraunhofer IME; Aachen Germany

3. RWTH Aachen University; Aachen Germany

4. Department of Chemistry; Universität für Bodenkultur (BOKU); Vienna Austria

5. Clinical Research Centre; Institute of Biosciences and Medicine; Faculty of Health & Medical Sciences; University of Surrey; Guildford Surrey UK

6. Department of Plant Production and Forestry Science; ETSEA; University of Lleida-Agrotecnio Center; Lleida Spain

7. Institució Catalana de Recerca i Estudis Avançats; Passeig Lluís Companys 23; Barcelona Spain

8. John Innes Centre; Norwich Research Park; Norwich UK

9. Polymun Scientific Immunbiologische Forschung GmbH; Klosterneuburg Austria

10. TRM Ltd; York UK

Funder

European Union for the Pharma-Planta project

CoMoFarm

COST Action Molecular Farming

Grand Challenges in Global Health

Wellcome Trust

ERC advanced grant Future-Pharma

Fraunhofer Gesellschaft

Publisher

Wiley

Subject

Plant Science,Agronomy and Crop Science,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pbi.12416/fullpdf

Reference46 articles.

1. Removal of parvovirus B19 from hemoglobin solution by nanofiltration;Abe;Artif. Cells Blood Substit. Immobil. Biotechnol.,2000

2. A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1;Armbruster;AIDS,2002

3. Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12;Armbruster;J. Antimicrob. Chemother.,2004

4. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection;Baba;Nat. Med.,2000

5. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral;Baird;Proc. Natl Acad. Sci. USA,2000

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards a seamless product and process development workflow for recombinant proteins produced by plant molecular farming;Biotechnology Advances;2024-10

2. High‐yield, plant‐based production of an antimicrobial peptide with potent activity in a mouse model;Plant Biotechnology Journal;2024-09-12

3. Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems;Heliyon;2024-09

4. Enhanced efficacy of glycoengineered rice cell‐produced trastuzumab;Plant Biotechnology Journal;2024-07-17

5. Recent advances in plant-based bioproduction;Journal of Bioscience and Bioengineering;2024-07